[1] MILLER FW.The Increasing Prevalence of Autoimmunity and Autoimmune Diseases: an Urgent Call to Action for Improved Understanding, Diagnosis, Treatment, and Prevention[J]. Current Opinion in Immunology, 2023, 80: 102266. [2] JIANG S, ZHANG Z, HUANG F, et al.Protective Effect of Low Molecular Weight Peptides from Solenocera Crassicornis Head against Cyclophosphamide-Induced Nephrotoxicity in Mice via the Keap1/Nrf2 Pathway[J]. Antioxidants (Basel, Switzerland), 2020, 9(8): 745. [3] VAN DE MEEBERG MM, FIDDER HH, OLDENBURG B, et al. Therapeutic Drug Monitoring of Methotrexate in Patients with Crohn’s Disease[J]. Alimentary Pharmacology & Therapeutics, 2023, 58(11-12): 1151-1162. [4] ANDRADE RJ, AITHAL GP, DE BOER YS, et al.Nomenclature, Diagnosis and Management of Drug-Induced Autoimmune-Like Hepatitis (DI-ALH): an Expert Opinion Meeting Report[J]. Journal of Hepatology, 2023, 79(3): 853-866. [5] YU YC, SHEN CY.Pathogenesis of Drug-Induced Liver Injury: Current Understanding and Future Needs[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2021, 37(11): 2515-2524. [6] MA SW, LIU CH, LIU XY, et al.Chinese Guideline for Diagnosis and Management of Drug-Induced Liver Injury (2023 Version)[J]. Chinese Journal of Gastroenterology(胃肠病学), 2023, 28(7): 397-431. [7] JACOBELLI J, BUSER AE, HEIDEN DL, et al.Autoimmunity in Motion: Mechanisms of Immune Regulation and Destruction Revealed by in vivo Imaging[J]. Immunological Reviews, 2022, 306(1): 181-199. [8] MARTINO VD, VERHOEVEN DW, VERHOEVEN F, et al.Busting the Myth of Methotrexate Chronic Hepatotoxicity[J]. Nature Reviews Rheumatology, 2023, 19(2): 96-110. [9] BJöRNSSON ES. Hepatotoxicity by Drugs: the Most Common Implicated Agents[J]. International Journal of Molecular Sciences, 2016, 17(2): 224. [10] WAN YM, WU JF, LI YH, et al.Prednisone is Not Beneficial for the Treatment of Severe Drug-Induced Liver Injury: an Observational Study (STROBE Compliant)[J]. 2019, 98(26): e15886. [11] BESSONE F, HILLOTTE G L, TAMAGNONE N, et al.Ursodeoxycholic Acid for the Management of Drug-Induced Liver Injury: Role of Hepatoprotective and Anti-Cholestatic Mechanisms[J]. Journal of Clinical and Translational Hepatology, 2025, 13(2): 162-168. [12] ZHANG LL, WEI W.Advance in Drug Treatment of Autoimmune Diseases[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2019, 35(2): 149-156. [13] NAMAEI P, GHADIRI F, JAMALI R, et al.Evaluation of Liver Injury in Multiple Sclerosis Patients Receiving Pulsed Steroid Therapy[J]. Multiple Sclerosis and Related Disorders, 2022, 65: 103968. [14] AHMAD J, LI YJ, PHILLIPS E, et al.Liver Injury Due to Intravenous Methylprednisolone in the Drug-Induced Liver Injury Network[J]. Liver International: Official Journal of the International Association for the Study of the Liver, 2025, 45(2): e16242. [15] ALIJOTAS-REIG J, ESTEVE-VALVERDE E, ANUNCIACI N-LLUNELLA, et al.Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: a Comprehensive Review[J]. Journal of Clinical Medicine, 2022, 11(3): 675. [16] SU YY.Discussion on Adverse Reactions of Aspirin in Clinical Application[J]. Journal of North Pharmacy(北方药学), 2020, 17(11): 174-175. [17] YU ML, LOU J, CHEN YG, et al.One Case of Acute Liver Failure in Children with Kawasaki Disease Induced by High-Dose Aspirin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(10): 989-991. [18] BONKOVSKY HL, GHABRIL M, NICOLETTI P, et al.Drug-Induced Liver Injury (DILI) Ascribed to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the USA-Update with Genetic Correlations[J]. Liver International: Official Journal of the International Association for the Study of the Liver, 2024, 44(6): 1409-1421. [19] ALKANDARI FM, MOHAMED HS, AHMED SA, et al.Protective Effects of Propolis and Chitosan Nanoparticles against Ibuprofen-Induced Hepatotoxicity in Albino Rats[J]. Diseases (Basel, Switzerland), 2024, 12(3): 49. [20] ABDEL GALIL SM.Hydroxychloroquine-Induced Toxic Hepatitis in a Patient with Systemic Lupus Erythematosus: a Case Report[J]. Lupus, 2015, 24(6): 638-640. [21] NOURI A, GHATREH-SAMANI K, AMINI-KHOEI H, et al.Ferulic Acid Exerts a Protective Effect Against Cyclosporine-Induced Liver Injury in Rats via Activation of the Nrf2/HO-1 Signaling, Suppression of Oxidative Stress, Inflammatory Response, and Halting the Apoptotic Cell Death[J]. Journal of Biochemical and Molecular Toxicology, 2023, 37(10): e23427. [22] KASSIANIDES C, NUSSENBLATT R, PALESTINE AG, et al.Liver Injury from Cyclosporine A[J]. Digestive Diseases and Sciences, 1990, 35(6): 693-697. [23] LV B, LIU L, LIU X, et al.Incidence, Clinical Features and Risk Factors of Tacrolimus Induced Idiosyncratic Liver injury in Renal Transplant Recipients: a Nested Case-Control Study[J]. Frontiers in Pharmacology, 2023, 14: 1126765. [24] FATIMA N, SHEIKH N, SATOSKAR AR, et al.Effect of Short-Term Tacrolimus Exposure on Rat Liver: an Insight into Serum Antioxidant Status, Liver Lipid Peroxidation, and Inflammation[J]. Mediators of Inflammation, 2021, 2021: 6613786. [25] MION F, NAPOLEON B, BERGER F, et al.Azathioprine Induced Liver Disease: Nodular Regenerative Hyperplasia of the Liver and Perivenous Fibrosis in a Patient Treated for Multiple Sclerosis[J]. Gut, 1991, 32(6): 715-717. [26] DUBINSKY MC, YANG H, HASSARD PV, et al.6-MP Metabolite Profiles Provide a Biochemical Explanation for 6-MP Resistance in Patients with Inflammatory Bowel Disease[J]. Gastroenterology, 2002, 122(4): 904-915. [27] MAKUUCHI M, KAKUTA Y, UMENO J, et al.Real-World NUDT15 Genotyping and Thiopurine Treatment Optimization in Inflammatory Bowel Disease: a Multicenter Study[J]. Journal of Gastroenterology, 2024, 59(6): 468-482. [28] CHEN W, LIU Y.Research Progress in Adverse Reactions Caused by Methotrexate in the Treatment of Rheumatoid Arthritis[J]. Practical Phar-macy and Clinical Remedies(实用药物与临床), 2023, 26(1): 88-92. [29] WANG C, LENG M, DING C, et al.Ferritinophagy-Mediated Ferroptosis Facilitates Methotrexate-Induced Hepatotoxicity by High-Mobility Group Box 1 (HMGB1)[J]. Liver International: Official Journal of the International Association for the Study of the Liver, 2024, 44(3): 691-705. [30] LI L, JU J, ZHUANG X, et al.Chemistry of Bairui Granules and Its Mechanisms in the Protective Effect against Methotrexate-Induced Liver Injury[J]. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 2024, 122: 155158. [31] ZHAO F, ZHANG LN, WANG YY.Acute Liver Injury Induce by Cyclophosphamide Treatment of Resistant Dermatomyositisacute Liver Injury Induce by Cyclophosphamide Treatment of Resistant Dermatomyositis[J]. Clinical Medication Journal(临床药物治疗杂志), 2019, 17(8): 23-25. [32] YOU T, ZHAO Y, LIU S, et al.Lactiplantibacillus Plantarum P101 Attenuated Cyclophosphamide-Induced Liver Injury in Mice by Regulating the Nrf2/ARE Signaling Pathway[J]. International Journal of Molecular Sciences, 2023, 24(17): 13424. [33] TIAN S, JIANG X, TANG Y, et al.Laminaria Japonica Fucoidan Ameliorates Cyclophosphamide-Induced Liver and Kidney Injury Possibly by Regulating Nrf2/HO-1 and TLR4/NF-ΚB Signaling Pathways[J]. Journal of the Science of Food and Agriculture, 2022, 102(6): 2604-2612. [34] YU CY, DIAO JP.Clinical Characteristics of Liver Injury Caused by Tripterygium Glycosides Tablets in Patients with Rheumatoid Arthritis[J]. Chinese Traditional Patent Medicine(中成药), 2024, 46(6): 2115-2117. [35] GUO Q, WU J, WANG Q, et al.Single-Cell Transcriptome Analysis Uncovers Underlying Mechanisms of Acute Liver Injury Induced by Tripterygium Glycosides Tablet in Mice[J]. Journal of Pharmaceutical Analysis, 2023, 13(8): 908-925. [36] TIAN YG, SU XH, LIU LL, et al.Overview of Hepatotoxicity Studies on Tripterygium Wilfordii in Recent 20 Years[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(16): 3399-3405. [37] WANG X, ZHANG Y, DING Z, et al.Cross-Talk Between the RAS-ERK and (Mtor Signalings-Associated) Autophagy Contributes to Tripterygium Glycosides Tablet-Induced Liver Injury[J]. Biomedicine & Pharmacotherapy, 2023, 160: 114325. [38] LI Y, LI S, XUE X, et al.Integrating Systematic Pharmacology-Based Strategy and Experimental Validation to Explore Mechanism of Tripterygium Glycoside on Cholangiocyte-Related Liver Injury[J]. Chinese Herbal Medicines, 2022, 14(4): 563-575. [39] BAI X, TAN TY.Research Progress in Reproductive and Hepatorenal Toxicological Mechanisms of Tripterygium Wilfordii[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2024, 21(10): 1192-1199. [40] ZHAO Q.Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date[J]. Biodrugs: Clinical Immuno-thera-peutics, Biopharmaceuticals and Gene Therapy, 2020, 34(2): 111-119. [41] VOLLMER O, FELTEN R, MERTZ P, et al.Characterization of Auto-Immune Hepatitis Associated with the Use of Anti-TNFΑ Agents: an Analysis of 389 Cases in Vigibase[J]. Autoimmunity Reviews, 2020, 19(3): 102460. [42] MEI L, WANG YY, ZHOU HF, et al.Literature Analysis of Drug-Induced Autoimmune Hepatitis Induced by Tumor Necrosis Factor-Α Inhib-itor[J]. China Pharmacy(中国药房), 2023, 34(24): 3030-3035. [43] BEAUDOIN JJ, CLEMENS L, MIEDEL MT, et al.The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver Injury[J]. International Journal of Molecular Sciences, 2023, 24(11): 9692. [44] OZAKI M.Cellular and Molecular Mechanisms of Liver Regeneration: Proliferation, Growth, Death and Protection of Hepatocytes[J]. Seminars in Cell & Developmental Biology, 2020, 100: 62-73. [45] HU X, LI J, FU M, et al.The JAK/STAT Signaling Pathway: from Bench to Clinic[J]. Signal Transduction and Targeted Therapy, 2021, 6(1): 402. [46] CLARKE B, YATES M, ADAS M, et al. The Safety of JAK-1 Inhib-itors[J]. Rheumatology (Oxford, England), 2021, 60(2): ii24-ii30. [47] BJöRNSSON HK, GUDBJORNSSON B, BJöRNSSON ES. Infliximab-Induced Liver Injury: Clinical Phenotypes, Autoimmunity and the Role of Corticosteroid Treatment[J]. Journal of Hepatology, 2022, 76(1): 86-92. [48] BJöRNSSON ES, MEDINA-CALIZ I, ANDRADE RJ, et al. Setting Up Criteria for Drug-Induced Autoimmune-Like Hepatitis Through a Systematic Analysis of Published Reports[J]. Hepatology Communications, 2022, 6(8): 1895-1909. [49] WORLAND T, CHIN KL, VAN LANGENBERG D, et al.Retrospective Study of Idiosyncratic Drug-Induced Liver Injury from Infliximab in an Inflammatory Bowel Disease Cohort: the IDLE Study[J]. Annals of Gastroenterology, 2020, 33(2): 162-169. [50] GHABRIL M, BONKOVSKY HL, KUM C, et al.Liver Injury from Tumor Necrosis Factor-Α Antagonists: Analysis of Thirty-Four Cases[J]. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association, 2013, 11(5): 558-564. [51] FRENCH JB, BONACINI M, GHABRIL M, et al.Hepatotoxicity Associated with the Use of Anti-TNF-α Agents[J]. Drug Safety, 2016, 39(3): 199-208. [52] BRUNNER HI, RUPERTO N, ZUBER Z, et al.Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial[J]. Arthritis & Rheumatology (Hoboken, NJ), 2021, 73(3): 530-541. [53] YU JK, YU WL, CHEN SQ, et al.Literature Case Analysis of Drug-Induced Liver Injury Induced by Vedolizumab[J]. Evaluation and Analysis of Drug-Use in Hospitals(中国医院用药评价与分析), 2025, 25(2): 230-234, 239. [54] KALUNIAN KC, FURIE R, MORAND EF, et al.A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus[J]. Arthritis & Rheumatology (Hoboken, NJ), 2023, 75(2): 253-265. [55] KOUR G, CHOUDHARY R, ANJUM S, et al.Phytochemicals Targeting JAK/STAT Pathway in the Treatment of Rheumatoid Arthritis: Is there a Future?[J]. Biochemical Pharmacology, 2022, 197: 114929. [56] MAZZA S, SORO S, VERGA MC, et al.Liver-Side of Inflammatory Bowel Diseases: Hepatobiliary and Drug-Induced Disorders[J]. World Journal of Hepatology, 2021, 13(12): 1828-1849. [57] HE SY, LIANG WH, SHAO KZ, et al.Clinical Characteristics of Patients with Drug-Induced Liver Injury in a Hospital and Rationality Analysis of Liver Protective Drugs[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2024, 17(33): 174-177. [58] JI R, MA LY, WANG YD, et al.A Case of Autoimmune Hepatitis with Drug-Induced Liver Injury[J]. Chinese Medical Care Repository(中国临床案例成果数据库), 2022, 4(1): E00269. [59] LI QR, YAO Y, XU ZY.Research Advances in Drug-Induced Autoimmune-Like Hepatitis[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2024, 40(6): 1255-1258. |